KRRO · Korro Bio, Inc. · Executive Compensation
$9.29
-0.15 (-1.59%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$136.80M
Shares
14.73M
Volume · Oct 21
116K
Avg daily vol (3M)
149.92K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ram Aiyar | Chief Executive Officer, President and Interim Chief Financial Officer | $3,119,591 |
| Kemi Olugemo | Former Chief Medical Officer | $2,341,530 |
| Vineet Agarwal | Former Chief Financial Officer | $1,719,273 |
| Jeffrey Cerio | Senior Vice President, General Counsel and Corporate Secretary | $1,578,451 |
| Loïc Vincent | Chief Scientific Officer | $1,573,067 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Kemi Olugemo | Chief Medical Officer | $2,730,512 |
| Jeffrey Cerio | Senior Vice President, General Counsel and Corporate Secretary | $1,546,330 |
| Ram Aiyar | Chief Executive Officer and President | $939,075 |
| Vineet Agarwal | Former Chief Financial Officer | $617,550 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | Former President and Chief Executive Officer | $3,878,265 |
| Ram Aiyar | Chief Executive Officer and President | $2,858,230 |
| Steven Colletti | Chief Scientific Officer | $1,647,368 |
| Christopher R. Loose | Former Chief Scientific Officer | $1,580,474 |
| Vineet Agarwal | Chief Financial Officer | $1,322,891 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | Former President and Chief Executive Officer | $3,159,278 |
| Christopher R. Loose | Former Chief Scientific Officer | $1,518,812 |
| Ram Aiyar | Chief Executive Officer and President | $1,196,545 |
| Vineet Agarwal | Chief Financial Officer | $629,008 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | President and Chief Executive Officer | $5,821,532 |
| Quentin McCubbin | Chief Manufacturing Officer | $3,303,416 |
| Carl P. LeBel | Chief Development Officer | $2,750,743 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | President and Chief Executive Officer | $5,217,638 |
| Peter P. Pfreundschuh | Chief Financial Officer | $4,351,036 |
| Wendy S. Arnold | Chief People Officer | $2,773,413 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | President and Chief Executive Officer | $7,364,604 |
| Christopher R. Loose | — | $2,894,515 |
| Christopher Loose | Chief Scientific Officer | $2,894,515 |
| Carl LeBel | Chief Development Officer | $2,217,219 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| David L. Lucchino | President and Chief Executive Officer | $743,700 |
| Christopher R. Loose | — | $578,134 |
| Christopher Loose | Chief Scientific Officer | $578,134 |
| Carl LeBel | Chief Development Officer | $477,721 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Olukemi A. Olugemo, M.D., FAAN | Chief Medical Officer | Resigned | 2025-11-12 |
| Ram Aiyar | interim Chief Financial Officer and principal financial officer | Appointed | 2025-10-08 |
| Vineet Agarwal | Chief Financial Officer | Resigned | 2025-10-08 |
| Oliver Dolan | principal accounting officer | Appointed | 2025-03-27 |
| Vineet Agarwal | Chief Financial Officer | Appointed | 2025-03-27 |
| Oliver Dolan | interim principal accounting officer | Appointed | 2025-02-11 |
| Ram Aiyar | interim principal financial officer | Appointed | 2025-02-11 |
| Katharine Knobil, M.D. | Class III director on the Board | Appointed | 2024-08-28 |
| David L. Lucchino | member of our Board of Directors | Resigned | 2024-08-28 |
| Steve Colletti, Ph.D. | Chief Scientific Officer | Resigned | 2024-06-21 |
| Rachel Meyers, Ph.D. | member of the NCG Committee | Appointed | 2023-11-29 |
| Rachel Meyers, Ph.D. | Class I director | Appointed | 2023-11-29 |
| Shelby Walker | General Counsel and Corporate Secretary | Appointed | 2023-11-06 |
| Todd Chappell | Chief Operating Officer | Appointed | 2023-11-06 |
| Steve Colletti | Chief Scientific Officer | Appointed | 2023-11-06 |
| Vineet Agarwal | Treasurer and Chief Financial Officer and principal financial officer and principal accounting officer | Appointed | 2023-11-06 |
| Ram Aiyar | President and Chief Executive Officer and principal executive officer | Appointed | 2023-11-06 |
| Nessan Bermingham | Chairperson of the Board | Appointed | 2023-11-06 |
| Timothy Pearson | Board (Class II director) | Appointed | 2023-11-06 |
| Jean-Francois Formela | Board (Class III director) | Appointed | 2023-11-06 |
| Nessan Bermingham | Board (Class I director) | Appointed | 2023-11-06 |
| Ali Behbahani | Board (Class II director) | Appointed | 2023-11-06 |
| Ram Aiyar | Board (Class III director) | Appointed | 2023-11-06 |
| David L. Lucchino | Board (Class I director) | Appointed | 2023-11-06 |
| David Lucchino | President and Chief Executive Officer and principal executive officer | Resigned | 2023-11-06 |
Leadership
- Christopher Loose CEO
- David L. Lucchino CEO, Board Member
- Ram Aiyar CEO, CFO, Board Member
- Nessan Bermingham Chairman, Board Member
- Peter P. Pfreundschuh CFO
- Richard M. Mitrano CFO, Chief Accounting Officer
- Vineet Agarwal CFO
- Todd Chappell COO
- Steve Colletti CTO
- Jeffrey Cerio General Counsel
- Michael D. Bookman General Counsel
- Shelby Walker General Counsel
- Oliver Dolan Chief Accounting Officer
- Ali Behbahani Board Member
- Carl P. LeBel Board Member
- Christopher R. Loose Board Member
- Jean-Francois Formela Board Member
- Katharine Knobil Board Member
- Katharine Knobil, M.D. Board Member
- Marc A. Cohen Board Member
- Quentin McCubbin Board Member
- Rachel Meyers, Ph.D. Board Member
- Timothy Pearson Board Member
- Wendy S. Arnold Board Member
Key facts
CIK
1703647
CUSIP
500946108
13F (30d)
12 filings
12 filers
Visit website
Investor relations